Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (2): 97-104.doi: 10.35541/cjd.20200802

• Guidelines and Consensus • Previous Articles     Next Articles

Diagnosis and treatment of acne inversa/hidradenitis suppurativa in China: an expert consensus statement (2021 version)

Consensus Writing Group on the Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in China   

  1. Consensus Writing Group on the Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in China
  • Received:2020-08-14 Revised:2020-12-20 Online:2021-02-15 Published:2021-01-29
  • Contact: Wang Baoxi E-mail:wangbx@vip.126.com

Abstract: 【Abstract】 Acne inversa (AI)/hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease that centers on the hair follicular unit because of follicular occlusion. It mainly presents as painful, deep-seated, inflamed lesions since puberty, and most commonly occurs in the apocrine gland-bearing areas. The etiology and pathogenesis of AI/HS involve internal and external factors, such as genetic susceptibility, inflammation and immunity, microorganisms, obesity and smoking. Treatment of AI/HS is difficult, and the current aim of treatment is to control the frequency and duration of disease flares and improve the quality of life. Treatment protocols of AI/HS should be based on the disease severity grade. Medical treatments include antibiotics, retinoids, biologics, immunosuppressive agents, antiandrogen agents, and so on, and adjuvant treatments include surgery and laser/light therapies. This consensus aims to further standardize the diagnosis and treatment procedures of AI/HS in China, so as to facilitate its diagnosis and treatment.

Key words: Hidradenitis suppurativa, Acne inversa, Diagnosis, Therapy, Consensus